Valuation: Ipca Laboratories Limited

Market Cap 500B 5.29B 4.72B 4.33B 3.93B 7.39B 7.56B 51.71B 20.73B 265B 19.87B 19.45B 839B P/E 2027 *
33x
P/E 2028 * 28.1x
Enterprise Value 490B 5.18B 4.62B 4.23B 3.85B 7.23B 7.4B 50.61B 20.29B 259B 19.45B 19.03B 821B EV / Sales 2027 *
4.46x
EV / Sales 2028 * 3.91x
Free-Float
54.94%
Yield 2027 *
0.29%
Yield 2028 * 0.31%
1 day+1.12%
1 week-0.44%
Current month+2.29%
1 month+1.48%
3 months+14.28%
6 months+28.81%
Current year+38.98%
1 week 1,910.5
Extreme 1910.5
1,995
1 month 1,797
Extreme 1797
1,995
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,276.1
Extreme 1276.1
2,038
3 years 971
Extreme 971
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+1.12%-0.44%+50.57%+103.34% 5.22B
+1.08%+10.88%+57.51%+139.99% 1,255B
+3.47%+1.74%+47.57%+81.77% 641B
+2.10%+2.09%+35.23%+106.77% 505B
+1.25%-0.73%+49.96%+66.94% 381B
+2.74%+5.40%+77.13%+42.36% 357B
+2.10%+3.90%+32.30%+59.38% 303B
+1.92%+9.87%+11.94%+36.47% 286B
+3.58%+5.83%+61.16%+75.26% 249B
+4.50%+9.91%+42.25%+115.64% 208B
Average +2.23%+2.50%+46.56%+82.79% 419.04B
Weighted average by Cap. +2.06%+3.89%+48.81%+94.13%

Financials

2027 *2028 *
Net sales 110B 1.16B 1.04B 950M 864M 1.62B 1.66B 11.36B 4.55B 58.17B 4.36B 4.27B 184B 123B 1.3B 1.16B 1.06B 964M 1.81B 1.85B 12.68B 5.08B 64.95B 4.87B 4.77B 206B
Net income 15.12B 160M 143M 131M 119M 223M 228M 1.56B 626M 8B 601M 588M 25.35B 17.9B 189M 169M 155M 141M 264M 270M 1.85B 741M 9.47B 711M 696M 30.01B
Net Debt -10.65B -113M -100M -92.09M -83.69M -157M -161M -1.1B -441M -5.64B -423M -414M -17.86B -19.96B -211M -188M -173M -157M -295M -302M -2.06B -827M -10.56B -793M -776M -33.46B
Projected Income Statement - Annual - Ipca Laboratories Limited
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-11-04 ₹1,972.00 +1.12% 402,858
26-11-03 ₹1,950.10 +0.01% 361,957
26-11-02 ₹1,949.90 +1.15% 213,868
26-10-30 ₹1,927.80 +0.08% 253,527
26-10-29 ₹1,926.20 -0.22% 190,810
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Ipca Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,972.00INR
Average target price
1,981.72INR
Spread / Average Target
+0.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ipca Laboratories Limited
  1. Stock Market
  2. Stocks
  3. IPCALAB Stock